| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |